Literature DB >> 15695737

Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors.

Patrick L Sinn1, Ankur J Shah, Maureen D Donovan, Paul B McCray.   

Abstract

Advances in gene transfer to the conducting airways for the treatment of pulmonary diseases such as cystic fibrosis have identified several vector classes that transduce airway epithelia in vitro and in animal models. One barrier to epithelial gene transfer is the rapid removal of materials from the airway surface via mucociliary clearance. This host defense mechanism limits gene transfer efficiency to airway epithelial cells. Here we show that formulation of gene transfer vectors with viscoelastic gels provides longer epithelial residence time and increases vector-mediated gene transfer efficiency. Gene transfer with adenoviral, adeno-associated, and lentiviral vectors all significantly improved after formulation with viscoelastic gels designed to slow mucociliary clearance. Importantly, viscoelastic gel formulations enhanced vector transduction to the conducting airways, the desired treatment target for diseases such as cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695737     DOI: 10.1165/rcmb.2004-0410OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

1.  The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways.

Authors:  Uta Griesenbach; Cuixiang Meng; Raymond Farley; Marguerite Y Wasowicz; Felix M Munkonge; Mario Chan; Charlotte Stoneham; Stephanie G Sumner-Jones; Ian A Pringle; Deborah R Gill; Stephen C Hyde; Barbara Stevenson; Emma Holder; Hiroshi Ban; Mamoru Hasegawa; Seng H Cheng; Ronald K Scheule; Patrick L Sinn; Paul B McCray; Eric W F W Alton
Journal:  Biomaterials       Date:  2009-12-21       Impact factor: 12.479

2.  Transcriptional targeting in the airway using novel gene regulatory elements.

Authors:  Erin R Burnight; Guoshun Wang; Paul B McCray; Patrick L Sinn
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-23       Impact factor: 6.914

Review 3.  Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Authors:  Mayumi Oakland; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

4.  Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.

Authors:  Patrick L Sinn; Erin R Burnight; Melissa A Hickey; Gary W Blissard; Paul B McCray
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.

Authors:  Ashley L Cooney; Brajesh K Singh; Patrick L Sinn
Journal:  Mol Ther       Date:  2015-01-05       Impact factor: 11.454

6.  Lentivirus vector can be readministered to nasal epithelia without blocking immune responses.

Authors:  Patrick L Sinn; Ariadna C Arias; Kim A Brogden; Paul B McCray
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung.

Authors:  David E Fein; Maria P Limberis; Sean F Maloney; Jack M Heath; James M Wilson; Scott L Diamond
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

8.  Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.

Authors:  Ashley L Cooney; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Mallory R Stroik; Linda S Powers; Nick D Gansemer; David K Meyerholz; Michael J Welsh; David A Stoltz; Patrick L Sinn; Paul B McCray
Journal:  JCI Insight       Date:  2016-09-08

9.  Lentiviral vector gene transfer to porcine airways.

Authors:  Patrick L Sinn; Ashley L Cooney; Mayumi Oakland; Douglas E Dylla; Tanner J Wallen; Alejandro A Pezzulo; Eugene H Chang; Paul B McCray
Journal:  Mol Ther Nucleic Acids       Date:  2012-11-27       Impact factor: 10.183

10.  Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors.

Authors:  Mayumi Oakland; Wendy Maury; Paul B McCray; Patrick L Sinn
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-29       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.